Back
Pfizer Vs. Moderna Industry Stock Comparison
Sell
38
PFE
Pfizer
Last Price:
$25.53
Seasonality Move:
2.76%
Sell
12
MRNA
Moderna
Last Price:
$33.00
Seasonality Move:
43.33%
Sell
38
Pfizer (PFE)
is a Sell
Is Pfizer a Buy, Sell or Hold?
-
PFE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PFE Stock Price Chart
PFE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.23 | Sell |
Relative Strength Index (14 RSI): | 41.88 | Sell |
Chaikin Money Flow: | -18699667 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.8 - 26.68) | Sell |
Bollinger Bands (100): | (25.59 - 28.43) | Sell |
MRNA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.33 | Sell |
Relative Strength Index (14 RSI): | 41.16 | Sell |
Chaikin Money Flow: | 15208512 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.34 - 40.5) | Sell |
Bollinger Bands (100): | (36.22 - 55.5) | Sell |
PFE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.76 | Sell |
20-day SMA: | 26.16 | Sell |
50-day SMA: | 26.19 | Sell |
200-day SMA: | 27.86 | Sell |
8-day EMA: | 25.74 | Sell |
20-day EMA: | 26.03 | Sell |
50-day EMA: | 26.33 | Sell |
200-day EMA: | 27.75 | Sell |
MRNA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 32.43 | Buy |
20-day SMA: | 36.51 | Sell |
50-day SMA: | 39.11 | Sell |
200-day SMA: | 79.4 | Sell |
8-day EMA: | 32.98 | Buy |
20-day EMA: | 35.41 | Sell |
50-day EMA: | 39.63 | Sell |
200-day EMA: | 66.44 | Sell |
Pfizer Earnings Growth & PFE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.14 per share, an increase this year of $0.03 per share, and an increase next year of $0.11 per share.
Moderna Earnings Growth & MRNA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.29 per share, a decrease next quarter of $1.05 per share, a decrease this year of $0.96 per share, and an increase next year of $2.65 per share.
Pfizer Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Moderna Technical Analysis
Feb 3 | Feb 4 | Feb 5 | Feb 6 | Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |